Wolverine Asset Management LLC Cerevel Therapeutics Holdings, Inc. Transaction History

Wolverine Asset Management LLC

  • $4.35 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$21.26 - $38.85 $260,498 - $476,029
-12,253 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$12.56 - $29.69 $43,671 - $103,232
3,477 Added 39.62%
12,253 $313,000
Q1 2021

May 13, 2021
BUY
$12.37 - $17.74 $108,559 - $155,686
8,776 New
8,776 $120,000

Others Institutions Holding CERE

# of Institutions
8
Shares Held
5.01M
Call Options Held
3.3K
Put Options Held
0
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email